| Control Subjects | HCM Subjects |
---|---|---|
(n = 15) | (n = 15) | |
LVIDd (cm) | 4.7 ± 0.6 | 4.3 ± 0.6 |
LVIDs (cm) | 3.2 ± 0.8 | 2.7 ± 0.5 |
LV end-diastolic volume (mL) | 102 ± 25 | 72 ± 18* |
LV end-systolic volume (mL) | 38 ± 10 | 30 ± 10 |
IVSd (cm) | 0.9 ± 0.3 | 1.9 ± 0.4* |
PWd (cm) | 1.0 ± 0.3 | 1.2 ± 0.4 |
LVEF (%) | 63 ± 7 | 72 ± 8* |
Stroke volume (mL) | 71 ± 10 | 80 ± 25 |
Stroke volume index (mL/m2) | 34 ± 11 | 38 ± 11 |
Cardiac output (L/min) | 4.9 ± 0.7 | 4.9 ± 1.2 |
Resting LVOT gradient (mm Hg) [IQR] | 4 [3–6] | 26 [8–52]* |
LV stroke work index (g/m) | 42 ± 10 | 98 ± 65* |
LV myocardial work index (g/m/min)a | 2870 ± 855 | 6014 ± 3720* |